Top 10 Drug Discovery and Development Consulting/Services Companies in Europe - 2019
pharmatechoutlook
Origenis: A NEW APPROACH TO SMALL MOLECULE DRUG DISCOVERY

Top 10 Drug Discovery and Development Consulting/Services Companies in Europe - 2019

In the pharmaceutical industry, the process of developing nascent drugs to cure a disease is quite long, costly, and at the same time uncertain. In light of this, many experts in this space cite that the costs of developing new drugs can be reduced by the use of new technologies and with a deep understanding of biology. Albeit the objectives of drug delivery remain the same, the methods and techniques used in drug development continue to experience radical changes. In a nutshell, the standard approach to drug discovery is to identify a single molecular disease target and subsequently identify a compound that interacts and modulates with high specificity. Today, majority of the innovation reinvigorating the drug development methodologies seeks to access and integrate more information – about targets, compounds, and disease phenotypes. Next, the increasing size of chemical libraries and high throughput screening (HTS) technologies have enabled thousands or millions of compounds to be screened and the concomitant increase in compounds have supplemented the urgency for the bioanalysis of metabolites, and a need for faster turnaround.

To assist CIOs maneuver in the right direction while working on Drug Discovery and Development, a distinguished panel of CEOs, CIOs, VCs, and analysts along with the Pharma Tech Outlook’s editorial board has selected the leading Drug Discovery and Development service providers in Europe. The companies featured in this edition demonstrate an ability to develop innovative technologies combined with outstanding customer service.

We present to you Top 10 Drug Discovery and Development Consulting/Services Companies in Europe - 2019.

Company Logo Company Name Company Description
Clarity Genomics Clarity Genomics support clinical development programs leveraging the therapeutic potential of the host microbiome
Euretos Provides an AI platform for pre & early-clinical researchers to discover in-silico & validation of targets and biomarkers
GENEL Provides state-of-the-art tech-stack to unlock the truth of cosmetic active ingredients and pharmaceutical drug candidates to accelerate the speed-to-market process
GENEWIZ Provides full-services in DNA sequencing, gene synthesis, molecular biology, next generation sequencing, bioinformatics, and GLP regulatory and clinical services
IRBM Offers a unique blend of broad scientific expertise, global pharma heritage, and unprecedented success in bringing drug discovery projects from conception to the clinic
Metabolon Metabolon is the world’s leading health technology company advancing metabolomics for precision medicine and every area of life sciences research
NeoVirTech The company provides ANCHOR, an autofluorescence technology for rapid and efficient viral vector imaging and antiviral discovery
Neox Clinical Research Neox conducts clinical trials for pharamaceutical, biotechnology, medical device companies, and other CRO’s throughout Europe with a focus on central and eastern Europe
Oncodesign Founded over 20 years ago Oncodesign is a biopharma company that fills in the innovation gaps in the healthcare industry, based on its unique precision medicine platform
Pharmetheus Pharmetheus offers pharmacometric services supporting drug development of compounds in all phases and in all therapeutic areas